Loading...

NAGE NIAGEN BIOSCIENCE INC Capital Structure Changes 8-K Filing

NGN

NG

NIAGEN BIOSCIENCE INC

(NAGE)

2023 8-K

Share Repurchase Increase

Financial Results Announced

Asset Sale Announcement

IP Agreement Update

Share Buyback Approved

Quarterly Earnings Report

Financial Outlook Boost

Financial Statements

Rights Offerings

Financial Statements

Financial Results

CEO Compensation Update

Accountant Change

Contract Agreement

Equity Offering Update

Earnings Announcement

Auditor Resignation

Management Change

Earnings Announcement

Appointment of Interim CFO

Resignation of CFO

Annual Meeting Results

Earnings Reports

Financial Results Announcement

Amendment to Financing Agre...

Earnings Reports

Earnings Reports

Equity Incentive Plan Amend...

Earnings Reports

Financial Results Announcement

Appointment of CFO

External Links:

ChromaDex Corp. approved an amendment to their 2017 Equity Incentive Plan, increasing the number of shares available for issuance by 3.65 million shares.

AI Assistant

NIAGEN BIOSCIENCE INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.